NSAID Labeling Revisions Revised By FDA; Compliance Date Extended
This article was originally published in The Tan Sheet
Executive Summary
FDA has deleted the part of its recommended heart risk warning for NSAIDs that discourages use for "longer than 10 days or more than the recommended dose.